ORKA Average Annual Return 10 Years

Growth of $10,000.00
With Dividends Reinvested Into ORKA

Also see:
• ORKA stock yearly return 2015
• ORKA stock yearly return 2016
• ORKA stock yearly return 2017
• ORKA stock yearly return 2018
• ORKA stock yearly return 2019
• ORKA stock yearly return 2020
• ORKA stock yearly return 2021
• ORKA stock yearly return 2022
• ORKA stock yearly return 2023
• ORKA stock yearly return 2024
• ORKA YTD return

Compare ORKA average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return

Start date:	01/26/2015
End date:	01/23/2025
Start price/share:	$8.64
End price/share:	$12.47
Starting shares:	1,157.41
Ending shares:	1,904.17
Dividends reinvested/share:	$19.36
Total return:	137.45%
ORKA Average Annual Return:	9.03%
Starting investment:	$10,000.00
Ending investment:	$23,738.87

ORKA average annual return is presented with the assumption of reinvestments of any dividends on ex-date.

Oruka Therapeutics, Inc., formerly ARCA biopharma, Inc., is a biotechnology company. Co. is engaged in developing novel biologics designed for the treatment of chronic skin diseases, including plaque psoriasis. It is advancing a proprietary portfolio of potential antibodies that target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases. Co.'s lead programs include ORKA-001 and ORKA-002, which are designed to block cytokines in the pathogenesis of psoriasis and other inflammatory diseases. ORKA-001 is a potentially monoclonal antibody designed to inhibit IL-23p19 for the treatment of psoriasis. The ORKA average annual return 10 years is shown above.

The Average Annual Return on the ORKA average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether ORKA average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the ORKA average annual return calculation with any dividends reinvested as applicable (on ex-dates).

Quotes delayed 20 minutes

Free ORKA Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

10 Most Oversold Stocks in the S&P

10 Most Overbought Stocks in the S&P

10 ETFs With Stocks That Insiders Are Buying

10 ETFs With Most Upside To Analyst Targets

The DividendRank Top 25

Warren Buffett Dividend Stocks

10 Cheap Dividend Stocks Under $10

10 Energy Stocks You Can Buy Cheaper Than Insiders Did

10 Top DividendRank'ed Energy Stocks

The 10 Highest Yielding Preferred Stocks

The 15 Most Active Call & Put Options of the S&P 500 Components

Video: Don't Forget Dividends in Average Annual Return!

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Oruka Therapeutics (ORKA) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

ORMP Average Annual Return
OSUR Average Annual Return
OTLK Average Annual Return
OTRK Average Annual Return
OVID Average Annual Return
OWLT Average Annual Return
PACB Average Annual Return
PACS Average Annual Return
PAHC Average Annual Return
PALI Average Annual Return
More Healthcare companies »

★★★★ Based on a ranking of our entire coverage universe by highest ten year average annual return, Oruka Therapeutics (ORKA) ranks within the highest 50% of all stocks whose returns we have reviewed.

What has the average annual return been for ORKA over the past ten years?

✔️Accepted answer: The ten year ORKA average annual return has been 9.03% with dividends reinvested.

When you say 'with dividends reinvested' what does that mean?

✔️Accepted answer: That means that each time the stock goes ex-dividend, the average annual return calculation then factors in how that dividend amount could have been reinvested into more shares of ORKA at the then-current price — often this is referred to as 'compounding' and is very important when considering average annual return over a long period like a full decade.

What start date was used in your ORKA average annual return calculation?

✔️Accepted answer: The start date was 01/26/2015.

What end date was used in your ORKA average annual return calculation?

✔️Accepted answer: The end date was 01/23/2025.

If I had invested $10,000 into ORKA ten years ago, how much would I have today?

✔️Accepted answer: With dividends reinvested, as of 01/23/2025, you would have $23,738.87.

What does that work out to on a total return basis?

✔️Accepted answer: The ORKA ten year total return ending 01/23/2025 works out to 137.45%.

ORKA Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2025, All Rights Reserved